Treatment of experimental colitis in mice with LMP-420, an inhibitor of TNF transcription-4

Ol samples obtained before DSS exposure began, at the end of each 5 day cycle of DSS administration, and after 16 days of recovery prior to beginning the next DSS cycle for wild type (n = 49–50 mice for days 0, 47, and 62, and n = 9 – 10 for the remaining time points) and RAG-2mice (n = 14). Mean cytokine concentrations per 100 mg stool are shown. Error bars are omitted for clarity. * indicates values significantly different from pre-treatment level for a given genotype. # indicates values significantly different (p ≤ 0.02) in wild type vs. RAG-2mice.<p><b>Copyright information:</b></p><p>Taken from "Treatment of experimental colitis in mice with LMP-420, an inhibitor of TNF transcription"</p><p>http://www.journal-inflammation.com/content/5/1/4</p><p>Journal of Inflammation (London, England) 2008;5():4-4.</p><p>Published online 10 Mar 2008</p><p>PMCID:PMC2322983.</p><p>